Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions Among Healthcare Workers of Adult and Pediatric Settings in Central Paris.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
27 01 2021
Historique:
received: 22 05 2020
accepted: 09 07 2020
entrez: 27 1 2021
pubmed: 28 1 2021
medline: 30 1 2021
Statut: ppublish

Résumé

Healthcare workers (HCWs) have paid a heavy toll during the coronavirus disease 2019 (COVID-19) outbreak. Routes of transmission remain to be fully understood. This prospective study compared a 1500-bed adult and 600-bed pediatric setting of a tertiary-care university hospital located in central Paris. From 24 February until 10 April 2020, all symptomatic HCWs were screened for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on a nasopharyngeal swab. HCWs screened positive were questioned on their profession, symptoms, and occupational and nonoccupational exposures to SARS-CoV-2. Among 1344 HCWs tested, 373 were positive (28%) and 336 (90%) corresponding questionnaires were completed. Three hospitalizations and no deaths were reported. Most HCWs (70%) had patient-facing occupational activities (22% in COVID-19 dedicated units). The total number of HCW cases peaked on 23 March, then decreased slowly, concomitantly with a continuous increase of compliance to preventive measures (including universal medical masking and personal protective equipment [PPE] for direct care to COVID-19 patients). Attack rates were of 3.2% and 2.3% in the adult and pediatric settings, respectively (P = .0022). In the adult setting, HCWs more frequently reported exposure to COVID-19 patients without PPE (25% vs 15%, P = .046). Report of contacts with children attending out-of-home care facilities dramatically decreased over the study period. Universal masking, reinforcement of hand hygiene, and PPE with medical masks for patients' care allowed protection of HCWs and containment of the outbreak. Residual transmissions were related to persistent exposures with undiagnosed patients or colleagues and not to contacts with children attending out-of-home care facilities.

Sections du résumé

BACKGROUND
Healthcare workers (HCWs) have paid a heavy toll during the coronavirus disease 2019 (COVID-19) outbreak. Routes of transmission remain to be fully understood.
METHODS
This prospective study compared a 1500-bed adult and 600-bed pediatric setting of a tertiary-care university hospital located in central Paris. From 24 February until 10 April 2020, all symptomatic HCWs were screened for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on a nasopharyngeal swab. HCWs screened positive were questioned on their profession, symptoms, and occupational and nonoccupational exposures to SARS-CoV-2.
RESULTS
Among 1344 HCWs tested, 373 were positive (28%) and 336 (90%) corresponding questionnaires were completed. Three hospitalizations and no deaths were reported. Most HCWs (70%) had patient-facing occupational activities (22% in COVID-19 dedicated units). The total number of HCW cases peaked on 23 March, then decreased slowly, concomitantly with a continuous increase of compliance to preventive measures (including universal medical masking and personal protective equipment [PPE] for direct care to COVID-19 patients). Attack rates were of 3.2% and 2.3% in the adult and pediatric settings, respectively (P = .0022). In the adult setting, HCWs more frequently reported exposure to COVID-19 patients without PPE (25% vs 15%, P = .046). Report of contacts with children attending out-of-home care facilities dramatically decreased over the study period.
CONCLUSIONS
Universal masking, reinforcement of hand hygiene, and PPE with medical masks for patients' care allowed protection of HCWs and containment of the outbreak. Residual transmissions were related to persistent exposures with undiagnosed patients or colleagues and not to contacts with children attending out-of-home care facilities.

Identifiants

pubmed: 33501952
pii: 5871438
doi: 10.1093/cid/ciaa977
pmc: PMC7454459
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

257-264

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Adrien Contejean (A)

Université de Paris, Faculté de Médecine, Paris, France.
Equipe Mobile d'Infectiologie, Assistance Publique-Hôpitaux de Paris, APHP.CUP, Hôpital Cochin, Paris, France.

Jérémie Leporrier (J)

Service de maladies infectieuses et tropicales, Assistance Publique-Hôpitaux de Paris, IHU Imagine, Hôpital Necker-Enfants malades, Paris, France.

Etienne Canouï (E)

Equipe Mobile d'Infectiologie, Assistance Publique-Hôpitaux de Paris, APHP.CUP, Hôpital Cochin, Paris, France.

Fanny Alby-Laurent (F)

Université de Paris, Faculté de Médecine, Paris, France.
Service de maladies infectieuses et tropicales, Assistance Publique-Hôpitaux de Paris, IHU Imagine, Hôpital Necker-Enfants malades, Paris, France.

Emmanuel Lafont (E)

Université de Paris, Faculté de Médecine, Paris, France.
Service de maladies infectieuses et tropicales, Assistance Publique-Hôpitaux de Paris, IHU Imagine, Hôpital Necker-Enfants malades, Paris, France.

Lauren Beaudeau (L)

Equipe Mobile d'Infectiologie, Assistance Publique-Hôpitaux de Paris, APHP.CUP, Hôpital Cochin, Paris, France.

Perrine Parize (P)

Service de maladies infectieuses et tropicales, Assistance Publique-Hôpitaux de Paris, IHU Imagine, Hôpital Necker-Enfants malades, Paris, France.

Fabienne Lecieux (F)

Service de santé au travail, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Paris, France.

Agnès Greffet (A)

Service de santé au travail, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants malades, Paris, France.

Gérard Chéron (G)

Université de Paris, Faculté de Médecine, Paris, France.
Service d'urgences pédiatriques, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants malades, Paris, France.

Rémy Gauzit (R)

Equipe Mobile d'Infectiologie, Assistance Publique-Hôpitaux de Paris, APHP.CUP, Hôpital Cochin, Paris, France.

Jacques Fourgeaud (J)

Laboratoire de virologie, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants malades, Paris, France.
EHU 7328 PACT, Institut Imagine, Université de Paris, Faculté de Médecine, Paris, France.

Anne-Sophie L'Honneur (AS)

Service de virologie, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Paris, France.

Jean-Marc Tréluyer (JM)

Département de soins intensifs pédiatriques, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants malades, Paris, France.
Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Université de Paris, Faculté de Médecine, Paris, France.
Département de pharmacologie clinique, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Paris, France.

Caroline Charlier (C)

Université de Paris, Faculté de Médecine, Paris, France.
Service de maladies infectieuses et tropicales, Assistance Publique-Hôpitaux de Paris, IHU Imagine, Hôpital Necker-Enfants malades, Paris, France.

Anne Casetta (A)

Equipe opérationnelle d'hygiène hospitalière, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Paris, France.

Pierre Frange (P)

EHU 7328 PACT, Institut Imagine, Université de Paris, Faculté de Médecine, Paris, France.
Laboratoire de microbiologie clinique, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants malades, Paris, France.

Marianne Leruez-Ville (M)

Laboratoire de virologie, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants malades, Paris, France.
EHU 7328 PACT, Institut Imagine, Université de Paris, Faculté de Médecine, Paris, France.

Flore Rozenberg (F)

Université de Paris, Faculté de Médecine, Paris, France.
Service de virologie, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Paris, France.

Olivier Lortholary (O)

Université de Paris, Faculté de Médecine, Paris, France.
Service de maladies infectieuses et tropicales, Assistance Publique-Hôpitaux de Paris, IHU Imagine, Hôpital Necker-Enfants malades, Paris, France.
Institut Pasteur, Molecular Mycology Unit, National Reference Centre for Invasive Mycoses and Antifungals, CNRS UMR 2000, Paris, France.

Solen Kernéis (S)

Equipe Mobile d'Infectiologie, Assistance Publique-Hôpitaux de Paris, APHP.CUP, Hôpital Cochin, Paris, France.
Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion (EMAE), Paris, France.
Université de Paris, INSERM, IAME, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH